Emergency Medicine A Comprehensive Study Guide

More brain disease reported by Biogen Idec

July 31, 2008 on 10:03 pm | In Uncategorized | Comments Off Biogen Idec Inc. of Cambridge, Mass., along with Elan Corp., reported to regulators two more cases of the potentially fatal brain infection PML among patients taking their multiple sclerosis drug Tysabri, the companies said Thursday.

Depomed posts $3.5M Q2 profit on litigation payment

July 31, 2008 on 8:32 pm | In Uncategorized | Comments Off Depomed Inc. reported net income of $3.5 million, or 7 cents a share for the second quarter, compared to a loss in the same period last year of $9 million, or 20 cents a share. (DEPO)

USF receives $128 million award for diabetes research

July 31, 2008 on 6:57 pm | In Uncategorized | Comments Off The National Institutes of Health awarded $128 million to a University of South Florida research team conducting worldwide studies on the prevention and treatment of juvenile diabetes. Jeffrey Krischer is leading the USF research team.

Gilead adds Alabama professor to board

July 31, 2008 on 5:12 pm | In Uncategorized | Comments Off HIV drug maker Gilead Sciences Inc. added Richard Whitley, M.D., a University of Alabama professor, to its board of directors. (GILD)

Ore Pharmaceuticals buys new drug for testing

July 31, 2008 on 4:42 pm | In Uncategorized | Comments Off Ore Pharmaceuticals Inc. has acquired a drug compound from Roche that it plans to take as its second candidate into clinical trials. (ORXE)